Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 52 Breast Neoplasms 24 Lung Neoplasms 21 Triple Negative Breast Neoplasms 16 Neoplasm Metastasis 16 Pancreatic Neoplasms 15 Neoplasms 15 Colorectal Neoplasms 14 Stomach Neoplasms 13 Head and Neck Neoplasms 12 Esophageal Neoplasms 12 Esophageal Squamous Cell Carcinoma 11 Uterine Cervical Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Small Cell Lung Carcinoma 9 Rectal Neoplasms 8 Ovarian Neoplasms 8 Leukemia, Myeloid, Acute 8 Recurrence 7 Nasopharyngeal Carcinoma 7 Glioblastoma 5 Fallopian Tube Neoplasms 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Mouth Neoplasms 4 Lymphoma 4 Endometrial Neoplasms 4 Colonic Neoplasms 4

Interventions

Fulvestrant 3 Carboplatin 2 repotrectinib 1 neratinib 1 Vorinostat 1 Trastuzumab 1 Taxes 1 Sampling Studies 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Adjuvant 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Mastectomy, Segmental 1 Mass Spectrometry 1 Magnetic Resonance Spectroscopy 1 Liquid Biopsy 1 Immunohistochemistry 1 High-Energy Shock Waves 1 Gene Expression Profiling 1 Fluorescent Antibody Technique 1 Drugs, Generic 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Crizotinib 1 Chromatography, Liquid 1 Blood Specimen Collection 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Lobular × Drug Therapy × 1 year × Clear all

NCT07613151 2026-05-29

NAPOLI

Istituto Oncologico Veneto IRCCS

Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡